UBS lowered the firm’s price target on Kimberly-Clark (KMB) to $132 from $151 and keeps a Neutral rating on the shares. Sentiment around Consumer Staples is as bearish despite underperforming the broader market by nearly 50% over the last two years, and UBS believes much of the negativity is “fair” amid a more favorable macro backdrop and risk-on environment over the past 24 months at a time when top and bottom line growth for majority of the group has underwhelmed vs. expectations, the analyst tells investors in a research note. It is difficult to find a fundamental narrative to get more constructive when layering in a stronger U.S. dollar, re-emerging commodity headwinds, rising bond yields, tariff uncertainty following the U.S. election, and long-term concerns on the potential implications of GLP-1 and broader health and wellness trends, the firm says. UBS would not recommend stepping in ahead of what will likely be a very challenging earnings season for the group.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KMB:
- Kimberly-Clark price target lowered to $124 from $140 at JPMorgan
- Trump Trade: President-elect prepares executive orders to boost fossil fuels
- Kimberly-Clark price target lowered to $118 from $125 at Citi
- Kimberly-Clark downgraded to Hold at TD Cowen on organic growth concerns
- Kimberly-Clark downgraded to Hold from Buy at TD Cowen